Tracing our origin back to 1939, the Glaucoma Center of San Francisco
has the largest number of glaucoma specialists in one location on the
West Coast. We’re proud of the team of Doctors we’ve assembled.
Dr. Shan Lin received his undergraduate degree from the University of California,
Berkeley and completed his medical school training at Tufts University School of
Medicine. He completed his ophthalmology residency and glaucoma fellowship training
at the University of California, San Francisco (UCSF). He has previously been Professor
of Clinical Ophthalmology at UCSF, including Director of the UCSF Glaucoma Service,
and at the Zuckerberg San Francisco General Hospital. Other leadership positions include
Executive Vice President of the World Glaucoma Association and Chair of the
Ambassador Committee for the American Glaucoma Society.
Dr. Lin has been selected annually for 'Best Doctors' in the U.S. since 2009. He has
received the American Academy of Ophthalmology’s Achievement Award, Secretariat
Award, and Senior Achievement Award. He is on the editorial boards for the American
Journal of Ophthalmology, Journal of Glaucoma, and American Journal of
Ophthalmology Case Reports. Dr. Lin has given numerous named lectures and speaks at
ophthalmology meetings nationally and internationally.
Dr. Lin’s areas of interest include angle-closure glaucoma, glaucoma among Asians,
cyclophotocoagulation for the treatment of glaucoma, and the role of cataract surgery in
glaucoma treatment. His past honors include the Heed Fellowship Award (Heed
Foundation), the Mid-Career Award (American Glaucoma Society), and the Glaucoma
Foundation’s Clinician-Scientist Awards. He has also been funded as a Principal
Investigator by the National Institutes of Health, including as the Principal Investigator at
UCSF for the Ocular Hypertension Treatment Study (OHTS). In addition, Dr. Lin has
been the Principal Investigator in San Francisco for many industry-sponsored clinical
trials, including the Memantine Glaucoma Trial by Allergan and the Ranibizumab-
Adjunctive Study for Ahmed Valve Surgery by Genentech.
Dr. Lin speaks some Mandarin Chinese.